Correlation Between Enliven Therapeutics and Day One
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Enliven Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Day One.
Diversification Opportunities for Enliven Therapeutics and Day One
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enliven and Day is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Day One go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Day One
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 1.11 times more return on investment than Day One. However, Enliven Therapeutics is 1.11 times more volatile than Day One Biopharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 2,443 in Enliven Therapeutics on December 1, 2024 and sell it today you would lose (360.00) from holding Enliven Therapeutics or give up 14.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Enliven Therapeutics vs. Day One Biopharmaceuticals
Performance |
Timeline |
Enliven Therapeutics |
Day One Biopharmaceu |
Enliven Therapeutics and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enliven Therapeutics and Day One
The main advantage of trading using opposite Enliven Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Day One vs. Beam Therapeutics | Day One vs. Editas Medicine | Day One vs. Caribou Biosciences | Day One vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Correlations Find global opportunities by holding instruments from different markets |